NIAID Hosts Virtual Meeting on AIDS Research Progress
Published Date: 7/17/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a public meeting on September 25, 2025, to discuss the latest updates on AIDS research. Anyone interested can watch online, and special accommodations are available if requested ahead of time. This meeting helps guide important health research and keeps the public in the loop without any cost to attend.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
NIAID AIDS meeting open to public
You can watch the National Institute of Allergy and Infectious Diseases (NIAID) AIDS Research Advisory Committee meeting on September 25, 2025 from 1:00 p.m. to 4:30 p.m. for free via the NIH Videocasting website. If you plan to attend in person at 5601 Fishers Lane, Grand Hall, Rockville, MD 20892, or need special assistance (for example, sign language), notify the contact person Martin Gutierrez at 240-292-4844 in advance.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Previous / Next Documents
Previous: 2025-13433 — Commercial Driver's License: State of Hawaii; Application for Exemption
Hawaii got the green light to skip some parts of the commercial driver’s license test for folks on Lanai and Molokai, letting them get a special restricted CDL. These drivers also don’t have to do the usual entry-level training. This new exemption keeps things safe and replaces the old one that ends in February 2026.
Next: 2025-13435 — National Institute of Allergy and Infectious Diseases; Notice of Meetings
The National Institute of Allergy and Infectious Diseases is holding public and private meetings on September 25, 2025, to review grant applications and share important updates. Scientists, researchers, and grant applicants will be affected as funding decisions and reports from top leaders are discussed. The open sessions will be streamed online, making it easy for anyone interested to tune in and stay informed.